| 图片 | 名称及描述 | |
|---|---|---|
|
O=S(C1=CC2=C([N+](C)=C(/C=C/C=C/C=C3N(CCCCCC(O)=O)C4=C(C=C(S(=O)(O)=O)C=C4)C/3(C)C)C2(C)C)C=C1)([O-])=O
97%
|
|
|
Olopatadine Impurity 16
95%
|
|
|
Olodaterol Impurity 16
95%
|
|
|
Opicapone impurity 3
95%
|
|
|
Opicapone Impurity 35
95%
|
|
|
Osimertinib Impurity 21
95%
|
|
|
Olmesartan Medoxomil Impurity 7
95%
|
|
|
Olmesartan Medoxomil Impurity D
95%
|
|
|
Oseltamivir EP Impurity E HCl
95%
|
|
|
Oseltamivir Impurity 42
95%
|
|
|
Oseltamivir Impurity 22
95%
|
|
|
Osimertinib Impurity 25
95%
|
|
|
Osimertinib Impurity 11
95%
|
|
|
Osimertinib Impurity 12
95%
|
|
|
Osimertinib Impurity 10
95%
|
|
|
Osimertinib Impurity 18
95%
|
|
|
Olopatadine USP Related Compound B
95%
|
|
|
Obeticholic Acid Impurity 26
95%
|
|
|
Ozagrel Impurity 16
95%
|
|
|
Olopatadine Acetaldehyde HCl
95%
|
0086-571-89925085
